2.43%XLF 15.10 
10.30%QQQQ 31.32 0.63%
Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
WALTHAM, Mass. - Thermo Fisher Scientific Inc. has acquired Open Biosystems Inc., a developer of tools to help scientists learn how to shut off genes that trigger disease.
| TMO | 41.01 |  -1.6 |
Thermo Fisher, a Waltham-based maker of scientific instruments and laboratory supplies, didn't disclose Tuesday how much it paid to acquire Open Biosystems. The Huntsville, Alabama-based company had $14 million in revenue last year, compared with Thermo Fisher's $10 billion.
Privately held Open Biosystems will immediately be folded into Thermo Fisher's Analytical Technologies business unit.
Open Biosystems makes tools to help researchers in the emerging field of RNA interference, also known as "gene-silencing." Scientists hope to use mechanisms within the body to target and "turn off" genes associated with disease.
Health officials are investigating an outbreak of a mystery disease in southern Africa which has so far claimed three lives.
The new soldiers in the upcoming prequel 'Halo 3: Recon' are "among the fiercest" in the popular game series, Microsoft says....
In last week's report, I held out the prospect that the US government rescue package might result in a change in sentiment in financial mark...
|
Professional Website Design For Corporate - Get a Free Quote Today
Partners   
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
